gdc

Web Exclusives

Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation
LeukemiaNewsworthyWeb Exclusives
Web Exclusives – May 11, 2018
This is the first treatment that targets patients with AML and the FLT3-ITD mutation. In this clinical trial, patients who received quizartinib lived longer without disease progression than those receiving chemotherapy.
Skin Cancer Awareness Month
MelanomaSlideshowsWeb Exclusives
Web Exclusives – May 1, 2018
May is Skin Cancer Awareness Month! View this slideshow to learn the latest statistics in the United States, leading causes and preventive measures, and quick facts on melanoma, one of the most common types of skin cancer. Conquer cancer with knowledge.
Breaking News: Sellas Announces Promising Data on NeuVax in Combination with Herceptin in HER2 1+/2+ Breast Cancer
Breast CancerNewsworthyWeb Exclusives
Web Exclusives – April 7, 2018
NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.
Testicular Cancer Awareness Month
SlideshowsWeb Exclusives
Web Exclusives – April 5, 2018
April is Testicular Cancer Awareness Month! Take a cruise through this slideshow full of facts about testicular cancer, such as the common risk factors and symptoms to look out for. Conquer cancer with knowledge.
Helping Patients Create a Legacy
Family MembersFrom Your NavigatorInfusion of HopeWeb Exclusives
Web Exclusives – March 14, 2018
Lillie Shockney shares a touching, personal story of an experience she had at the Young Survival Coalition Summit, where she held a workshop called “Building Your Legacy."
Colorectal Cancer Awareness Month
Colorectal CancerSlideshowsWeb Exclusives
Web Exclusives – March 1, 2018
March is Colorectal Cancer Awareness Month! Flip through this slideshow featuring the top risk factors for colorectal cancer, symptoms to look out for, and more. Conquer cancer with knowledge.
Blood-Based Biopsy Can Predict Breast Cancer Recurrence
Breast CancerWeb Exclusives
Web Exclusives – February 26, 2018
In patients with HR-positive breast cancer, a positive circulating tumor cells assay result was associated with nearly a 20-fold increased risk for recurrence of disease.
The Benefit of CDK4/6 Inhibitors Applies Equally to Older Women with Breast Cancer
Breast CancerWeb Exclusives
Web Exclusives – February 26, 2018
Older women with hormone receptor–positive, HER2-negative metastatic breast cancer who are treated with a CDK4/6 inhibitor may derive benefits similar to those seen in their younger counterparts.
Immunotherapy Continues to Gain Momentum in Breast Cancer
Breast CancerWeb Exclusives
Web Exclusives – February 26, 2018
Treatment with a regimen of pembrolizumab plus trastuzumab in patients with trastuzumab-resistant advanced HER2-positive breast cancer was well-tolerated and had clinical benefit in those whose tumors were positive for a biomarker for pembrolizumab.
Arm Morbidity Higher with Extensive Lymph Node Surgery in Younger Patients with Breast Cancer
Breast CancerWeb Exclusives
Web Exclusives – February 26, 2018
Patients under age 40 with breast cancer who underwent axillary lymph node dissection were more likely to experience arm swelling and decreased range of arm motion than patients who received less invasive sentinel lymph node biopsies.
Page 1 of 6
Results 1 - 10 of 56

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country